|
| |||||||||||
| |||||||||||
Full Screen- TITLE
- DEDICATION
- CERTIFICATE
- CERTIFICATE
- DECLARATION
- ACKNOWLEDGEMENT
- ABBREVIATIONS
- CONTENTS
- PREFACE
- SECTION A GlENERAL INTRODUCTION
- SECTION B PHYTHERAPY- A REVIEW
- Review on medicinal plants selected for the study
- SECTION C ANTlCANCEROUS PROPERTY OF MEDICINAL PLANTS
- 1. MEDICINAL PLANTS AND CANCER
- 2. SCREENING OF MEDICINAL PLANTS
- CYTOTOXIC STUDIES
- 3. METHODOLOGY RELATED TO PLANT DRUG AND CANCER
- 3.1 EXPERIMENTAL ANIMALS
- 3.2 TUMOUR CELL LINE AND THEIR MAINTENANCE
- 3.3 SOLID TUMOUR INDUCTION
- 3.4 PREPARATION OF THE DRUG FOR THE EXPERIMENTAL STUDY
- 3.5 PARTIAL PURIFICATION OF THE CRUDE DRUG
- 3.6 DRUG ADMINISTRATION
- 3.7 STUDY OF SURVIVAL PERICD
- 3.8 SOLID TUMOUR REDUCTION STUDIES
- 3.9 STUDY OF CHANGES IN BODY WEIGHT
- 3.10 GROUPING OF ANIMALS FOR DALTONS LYMPHOMA AND EHRLICH ASCITES LYMPHOMA
- 3.11 METHODS USED FOR THE B OCHEMICAL ANALYSIS
- 4. THE DRUG AND CANCER
- 4.1 SURVIVAL PERIOD AND CHANGE IN BODY WEIGHT
- 4.2 ANTIOXIDANT AND DETOXIFYING ENZYMES IN DALTONS LYMPHOMA AND EHRLICHS LYMPHOMA
- 4.3 ANTIOXIDANTS IN MICE BEARING DALTONS LYMPHOMA ASCITES (DLA) AND EHRLICHS ASCITES LYMPHOMA (EAC)
- 4.4 LIPID PEROXIDATION PRODUCTS IN MICE BEARING DALTONS ASCITES LYMPHOMA (DLA) AND EHRLICHS ASCITES LYMPHOMA (EAC)
- 4.5 SERUM ENZYMES IN MICE BEARING DALTONS ASCITES LYMPHOMA (DLA) AND EHRLICHS ASCITES LYMPHOMA (EAC)
- 4.6 BLOOD HAEMOGLOBIN LEVELS IN MICE BEARING DALTONS ASCITES LYMPHOMA (DLA) AND EHRLICHS ASCITES LYMPHOMA (EAC)
- 4.7 PROTEIN LEVELS IN MICE BEARING DALTONS ASCITES LYMPHOMA (DLA) AND EHRLICHS ASCITES LYMPHOMA (EAC)
- 4.8 SOLID TUMOUR STUDIES
- 5. SUMMARY
- SECTION D ANTI ATHEROGENIC PROPERTIES OF MEDICINAL PLANTS
- 1. MEDICINAL PLANTS AND ATHEROSCLEROSIS
- 2. SCREENING OF MEDlCINAL PLANTS
- 3. METHODOLOGY RELATED TO PLANT DRUG AND ATHEROSCLEROSIS
- 3.1 EXPERIMENTAL ANIMALS
- 3.2 PREPARATION OF THE DRUG FOR THE EXPERIMENTAL STUDY
- 3.3 DRUG ADMINISTRATION
- 3.4 GROUPING OF ANIMALS FOR THE EXPERIMENTAL STUDY
- 3.5 METHODOLOGY FOR BIOCHEMICAL ANALYSIS
- 4. THE DRUG AND ATHEROSCLEROSIS
- 4.1 STUDY OF CHANGE IN BODY WEIGHT AND ORGAN WEIGHT
- 4.2 EFFECT OF THE CRUDE PLANT DRUG ON FREE RADICAL METABOLISM
- 4.3 EFFECT OF CRUDE PLANT DRUG ON LIPID METABOLISM
- 5. SUMMARY
- SECTION E STRUCTURAL CHARACTERISTAION OF AN ACTIVE PRINCIPLE ISOLATED FROM CENTEL LA ASIATICA
- Experimental details
- Antitumour studies using DLA and EAC
- Inferences of spectral studies
- APPENDICES
- REFERENCES